Literature DB >> 9393289

Prognostic implications of cytogenetic findings in kidney cancer.

P Elfving1, N Mandahl, R Lundgren, J Limon, E Bak-Jensen, M Fernö, H Olsson, F Mitelman.   

Abstract

OBJECTIVE: To evaluate the prognostic impact of cytogenetic findings in renal cell carcinoma (RCC). PATIENTS AND METHODS: Tumour cytogenetics, histomorphology, DNA ploidy and S-phase fraction, stage, size, and grade were related to survival in 50 consecutive patients with RCC. The mean follow-up was 3.9 years (median 4.2, range 0-8.8).
RESULTS: The predictive probability for recurrence-free survival at 5 years (5-year RFS) for all 50 patients was 0.54. There was a significant association between the degree of cytogenetic complexity and survival, in that patients with five or less aberrations had a better prognosis than those with more than five changes (5-year RFS 0.71 and 0.43, respectively; P < 0.05). Patients with del(8p)/-8, +12, and +20 had a significantly worse prognosis compared with those without these aberrations. Of the well-known prognostic variables grade and stage, the former was far better for predicting prognosis. A Spearman correlation test showed a significant covariation of grade with the S-phase fraction, T-stage, and cytogenetic complexity.
CONCLUSION: The degree of cytogenetic complexity and recurrent cytogenetic abnormalities affect the prognosis in RCC, although grade was the most reliable independent prognostic factor predicting disease recurrence.

Entities:  

Mesh:

Year:  1997        PMID: 9393289     DOI: 10.1046/j.1464-410x.1997.00439.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  7 in total

Review 1.  Renal cell carcinoma deep sequencing: recent developments.

Authors:  Leslie J Farber; Kyle Furge; Bin Tean Teh
Journal:  Curr Oncol Rep       Date:  2012-06       Impact factor: 5.075

2.  Relevance of arm somatic copy number alterations for oncologic outcomes and tumor immune microenvironment in clear cell renal cell carcinoma.

Authors:  Ying Xiong; Yu Qi; Qi Bai; Yu Xia; Li Liu; Jianming Guo
Journal:  Ann Transl Med       Date:  2019-11

3.  Systematic evaluation of the prognostic impact and intratumour heterogeneity of clear cell renal cell carcinoma biomarkers.

Authors:  Sakshi Gulati; Pierre Martinez; Tejal Joshi; Nicolai Juul Birkbak; Claudio R Santos; Andrew J Rowan; Lisa Pickering; Martin Gore; James Larkin; Zoltan Szallasi; Paul A Bates; Charles Swanton; Marco Gerlinger
Journal:  Eur Urol       Date:  2014-07-19       Impact factor: 20.096

Review 4.  Renal Cancer in Recipients of Kidney Transplant.

Authors:  Prajwal Dhakal; Smith Giri; Krishmita Siwakoti; Supratik Rayamajhi; Vijaya Raj Bhatt
Journal:  Rare Tumors       Date:  2017-03-24

5.  Genetic characterization of Polish ccRCC patients: somatic mutation analysis of PBRM1, BAP1 and KDMC5, genomic SNP array analysis in tumor biopsy and preliminary results of chromosome aberrations analysis in plasma cell free DNA.

Authors:  Katarzyna Kluzek; Malgorzata I Srebniak; Weronika Majer; Agnieszka Ida; Tomasz Milecki; Kinga Huminska; Robert M van der Helm; Adrian Silesian; Tomasz M Wrzesinski; Jacek Wojciechowicz; Berna H Beverloo; Zbigniew Kwias; Hans A R Bluyssen; Joanna Wesoly
Journal:  Oncotarget       Date:  2017-04-25

6.  Somatic Copy Number Alterations and Associated Genes in Clear-Cell Renal-Cell Carcinoma in Brazilian Patients.

Authors:  Flávia Gonçalves Fernandes; Henrique Cesar Santejo Silveira; João Neif Antonio Júnior; Rosana Antunes da Silveira; Luis Eduardo Zucca; Flavio Mavignier Cárcano; André Octavio Nicolau Sanches; Luciano Neder; Cristovam Scapulatempo-Neto; Sergio Vicente Serrano; Eric Jonasch; Rui Manuel Reis; Adriane Feijó Evangelista
Journal:  Int J Mol Sci       Date:  2021-02-25       Impact factor: 5.923

Review 7.  Novel concepts in the staging of renal cell carcinoma.

Authors:  Dan Leibovici; Arie Lindner; Avishay Sella; Amnon Zisman
Journal:  Curr Urol Rep       Date:  2003-02       Impact factor: 2.862

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.